- Home
- TXG vs BSTZ Comparison
TXG vs BSTZ Comparison
Compare TXG & BSTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXG
- BSTZ
- Stock Information
- Founded
- TXG 2012
- BSTZ 2019
- Country
- TXG United States
- BSTZ United States
- Employees
- TXG N/A
- BSTZ N/A
- Industry
- TXG Biotechnology: Laboratory Analytical Instruments
- BSTZ Trusts Except Educational Religious and Charitable
- Sector
- TXG Industrials
- BSTZ Finance
- Exchange
- TXG Nasdaq
- BSTZ Nasdaq
- Market Cap
- TXG 1.3B
- BSTZ 1.4B
- IPO Year
- TXG 2019
- BSTZ N/A
- Fundamental
- Price
- TXG $14.11
- BSTZ $21.24
- Analyst Decision
- TXG Buy
- BSTZ
- Analyst Count
- TXG 12
- BSTZ 0
- Target Price
- TXG $14.13
- BSTZ N/A
- AVG Volume (30 Days)
- TXG 3.7M
- BSTZ 303.2K
- Earning Date
- TXG 08-07-2025
- BSTZ 01-01-0001
- Dividend Yield
- TXG N/A
- BSTZ 8.31%
- EPS Growth
- TXG N/A
- BSTZ N/A
- EPS
- TXG N/A
- BSTZ 0.71
- Revenue
- TXG $624,662,000.00
- BSTZ N/A
- Revenue This Year
- TXG N/A
- BSTZ N/A
- Revenue Next Year
- TXG $5.69
- BSTZ N/A
- P/E Ratio
- TXG N/A
- BSTZ $26.69
- Revenue Growth
- TXG N/A
- BSTZ N/A
- 52 Week Low
- TXG $6.78
- BSTZ $14.11
- 52 Week High
- TXG $24.76
- BSTZ $19.43
- Technical
- Relative Strength Index (RSI)
- TXG 68.91
- BSTZ 69.05
- Support Level
- TXG $11.45
- BSTZ $20.97
- Resistance Level
- TXG $14.16
- BSTZ $21.34
- Average True Range (ATR)
- TXG 0.71
- BSTZ 0.26
- MACD
- TXG 0.08
- BSTZ 0.02
- Stochastic Oscillator
- TXG 93.01
- BSTZ 91.45
About TXG 10x Genomics Inc.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
About BSTZ BlackRock Science and Technology Term Trust of Beneficial Interest
BlackRock Science and Technology Trust II is a non-diversified, closed-end management investment company. The trust's investment objectives are to provide total return and income through a combination of current income, current gains, and long-term capital appreciation. Its portfolio consists of Equity Securities, Options, Preferred Securities, Convertible Securities, Depositary Receipts, Non-U.S. Securities, Emerging Markets Investments, Restricted and Illiquid Investments, Private Company Investments, Corporate Bonds, and other investments. The trust seeks to Invest at least 80% of its total assets in equity securities issued by U.S. and non-U.S. science and technology companies in any market capitalization range from the development, advancement, and use of science and/or technology.